AAAAAA
Results:
1-20
|
Results: 20
Authors:
LIU WM
POELE RHT
JOEL SP
Citation: Wm. Liu et al., RE - LOSS OF DNA MISMATCH REPAIR - EFFECTS ON THE RATE OF MUTATION TODRUG-RESISTANCE, Journal of the National Cancer Institute, 90(3), 1998, pp. 246-246
Authors:
LIU WM
BAMFORD C
SLEVIN M
JOEL SP
Citation: Wm. Liu et al., EFFECTS OF HEMATOPOIETIC GROWTH-FACTORS IN COMBINATION WITH ETOPOSIDEON SISTER-CHROMATID EXCHANGE FREQUENCIES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 343-346
Authors:
WARD SA
JOEL SP
PAPAMICHAEL D
SLEVIN ML
GLYNNEJONES R
Citation: Sa. Ward et al., THYMIDYLATE SYNTHASE (TS) AND P53 PROTEIN EXPRESSION IN PATIENTS WITHRECTAL-CANCER TREATED WITH PREOPERATIVE 5-FLUOROURACIL (5-FU) BASED CHEMORADIOTHERAPY (CRT), British Journal of Cancer, 78, 1998, pp. 8-8
Authors:
PAPAMICHAEL D
JOEL SP
SEYMOUR M
RICHARDS F
BOWERBANK M
SLEVIN ML
Citation: D. Papamichael et al., PHARMACOKINETIC (PK) INTERACTION BETWEEN 5-FLUOROURACIL (5-FU) AND OXALIPLATIN (L-OHP), British Journal of Cancer, 78, 1998, pp. 32-32
Authors:
BARRATT PL
SEYMOUR MT
STENNING S
JOEL SP
QUIRKE P
Citation: Pl. Barratt et al., IDENTIFYING MOLECULAR MARKERS PREDICTIVE OF SURVIVAL AND BENEFIT FROMADJUVANT 5-FLUOROURACIL IN COLON-CANCER, British Journal of Cancer, 78, 1998, pp. 5-5
Authors:
JOEL SP
SHAH R
CLARK PI
SLEVIN ML
Citation: Sp. Joel et al., PREDICTING ETOPOSIDE TOXICITY - RELATIONSHIP TO ORGAN FUNCTION AND PROTEIN-BINDING, Journal of clinical oncology, 14(1), 1996, pp. 257-267
Authors:
WATSON NW
TAYLOR KMG
JOEL SP
SLEVIN ML
EDEN OB
Citation: Nw. Watson et al., A PHARMACOKINETIC STUDY OF SUBLINGUAL AEROSOLIZED MORPHINE IN HEALTHY-VOLUNTEERS, Journal of Pharmacy and Pharmacology, 48(12), 1996, pp. 1256-1259
Authors:
JOEL SP
CLARK PI
SLEVIN ML
Citation: Sp. Joel et al., STABILITY OF THE IV AND ORAL FORMULATIONS OF ETOPOSIDE IN SOLUTION, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 117-124
Authors:
JOEL SP
CLARK PI
HEAP L
WEBSTER L
ROBBINS S
CRAFT H
SLEVIN ML
Citation: Sp. Joel et al., PHARMACOLOGICAL ATTEMPTS TO IMPROVE THE BIOAVAILABILITY OF ORAL ETOPOSIDE, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 125-133
Authors:
THOMPSON PI
JOEL SP
JOHN L
WEDZICHA JA
MACLEAN M
SLEVIN ML
Citation: Pi. Thompson et al., RESPIRATORY DEPRESSION FOLLOWING MORPHINE AND MORPHINE 6-GLUCURONIDE IN NORMAL SUBJECTS, British journal of clinical pharmacology, 40(2), 1995, pp. 145-152
Authors:
CHAPMAN DJ
CROSS MJ
JOEL SP
AHERNE GW
Citation: Dj. Chapman et al., A SPECIFIC RADIOIMMUNOASSAY FOR THE DETERMINATION OF MORPHINE-6-GLUCURONIDE IN HUMAN PLASMA, Annals of clinical biochemistry, 32, 1995, pp. 297-302
Authors:
PLOWMAN PN
JOEL SP
HERMAN S
Citation: Pn. Plowman et al., ETOPOSIDE PHARMACOKINETICS IN A JAUNDICED INFANT WITH LETTERER-SIWE VARIANT OF LANGERHANS CELL HISTIOCYTOSIS, Oncology Reports, 1(6), 1994, pp. 1233-1234
Authors:
CLARK PI
SLEVIN ML
JOEL SP
OSBORNE RJ
TALBOT DI
JOHNSON PWM
REZNEK R
MASUD T
GREGORY W
WRIGLEY PFM
Citation: Pi. Clark et al., A RANDOMIZED TRIAL OF 2 ETOPOSIDE SCHEDULES IN SMALL-CELL LUNG-CANCER- THE INFLUENCE OF PHARMACOKINETICS ON EFFICACY AND TOXICITY, Journal of clinical oncology, 12(7), 1994, pp. 1427-1435
Authors:
CHAPMAN DJ
JOEL SP
AHERNE GW
Citation: Dj. Chapman et al., EVALUATION OF A DIFFERENTIAL RADIOIMMUNOASSAY TECHNIQUE FOR THE DETERMINATION OF MORPHINE AND MORPHINE-6-GLUCURONIDE IN HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 12(3), 1994, pp. 353-360
Authors:
JOEL SP
SHAH R
SLEVIN ML
Citation: Sp. Joel et al., ETOPOSIDE DOSAGE AND PHARMACODYNAMICS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000069-190000075
Authors:
JOEL SP
SLEVIN ML
Citation: Sp. Joel et Ml. Slevin, SCHEDULE-DEPENDENT TOPOISOMERASE II-INHIBITING DRUGS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000084-190000088
Authors:
JOEL SP
OSBORNE RJ
SLEVIN ML
Citation: Sp. Joel et al., MORPHINE IN KIDNEY FAILURE - REPLY, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 114-114
Authors:
JOEL SP
Citation: Sp. Joel, TAXOL AND TAXOTERE - FROM YEW TREE TO TUMOR-CELL, Chemistry and Industry, (5), 1994, pp. 172-175
Authors:
SEYMOUR MT
PATEL N
JOHNSTON A
JOEL SP
SLEVIN ML
Citation: Mt. Seymour et al., LACK OF EFFECT OF INTERFERON ALPHA-2A UPON FLUOROURACIL PHARMACOKINETICS, British Journal of Cancer, 70(4), 1994, pp. 724-728
Authors:
SLEVIN ML
JOEL SP
Citation: Ml. Slevin et Sp. Joel, PROLONGED ORAL ETOPOSIDE IN SMALL-CELL LUNG-CANCER, Annals of oncology, 4(7), 1993, pp. 529-532
Risultati:
1-20
|